Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CAPRthis companyCapricor Therapeutics, Inc.	$9.02	-12.77×	4.39×	0×	-10.7×	-20.2%	0.0%	0.0%	0.0%	-34.4%	-33.4%	-5.4%	0.06×	2.7×	-35.51×	9.01×	0.0%	2	0.16	2	C
DYNDyne Therapeutics, Inc.	$18.46	-5.64×	2.58×	0×	-3.74×	-61.0%	0.0%	0.0%	0.0%	-45.9%	-41.0%	-16.1%	0.02×	1.99×	-75.61×	22.25×	0.0%	2	3.6	2	C+
EWTXEdgewise Therapeutics, Inc.	$45.72	-15.23×	4.89×	0×	-15.09×	-98.7%	0.0%	0.0%	0.0%	-32.1%	-36.4%	-5.6%	0.01×	0.35×	0×	19.85×	0.0%	1	75.67	2	C
IONSIonis Pharmaceuticals, Inc.	$28.19	-33.24×	25.88×	13.41×	-52.41×	-292.2%	98.3%	-40.5%	-40.4%	-77.9%	-12.0%	-2.5%	5.35×	-7.89×	-4.22×	3.83×	0.0%	2	0.89	1	D+
PEPGPepGen Inc.	$2.46	-3.07×	1.86×	0×	-2.62×	-56.9%	0.0%	0.0%	0.0%	-60.8%	-56.9%	-29.8%	0.12×	0.49×	0×	11.94×	0.0%	2	-0.25	2	C+
PTCTPTC Therapeutics, Inc.	$64.46	8.85×	-29.43×	3.49×	8.75×	-1377.4%	95.9%	49.5%	39.4%	-332.5%	33.4%	6.8%	-13.19×	1.94×	5.63×	2.35×	0.0%	4	0.75	2	C
Peer median	—	-5.64×	2.58×	0×	-3.74×	-98.7%	0.0%	0.0%	0.0%	-60.8%	-36.4%	-5.6%	0.02×	0.49×	0×	11.94×	0.0%	2	0.89	2	—